![Mark L. Smythe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark L. Smythe
Directeur Général chez
Infensa Bioscience Pty Ltd.
Profil
Mark L.
Smythe is the founder of Protagonist Therapeutics, Inc. which was founded in 2006.
He held the title of Vice President-Technology from 2013 to 2022.
Currently, he is the Chief Executive Officer at Infensa Bioscience Pty Ltd. since 2022.
He previously worked at GSK Plc as a Principal.
Dr. Smythe obtained a doctorate from the University of Melbourne and an undergraduate degree from James Cook University.
Postes actifs de Mark L. Smythe
| Sociétés | Poste | Début |
|---|---|---|
Infensa Bioscience Pty Ltd. | Directeur Général | 01/05/2022 |
Anciens postes connus de Mark L. Smythe
| Sociétés | Poste | Fin |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Fondateur | 01/05/2022 |
| GSK PLC | Corporate Officer/Principal | - |
Formation de Mark L. Smythe
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
33
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
James Cook University
 James Cook University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagonist Therapeutics, Inc.
 Protagonist Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures peptide based therapeutic products | Health Technology |
Infensa Bioscience Pty Ltd. |
